Product Information
AMPHETAMINE ER 12.5 MG ODT is a generic product labeled by Neos Therapeutics Brands, LLC, priced at $16.3218 per EA under NDC 62542002030. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
12.5 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
62542002030
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA204326On Market Since
9/1/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 12.5 MG ODT has been published 28 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.3218 per EA |
|---|---|
| All-time high | $16.5820 (Apr 15, 2026) |
| All-time low | $16.3218 (Jun 17, 2026) |
| 52-week high | $16.5820 |
| 52-week low | $16.3218 |
| Median price | $16.5570 |
| Average price | $16.5283 |
| Largest weekly change | -0.8% (May 20, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amphetamine Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 12.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 12.5 MG ODT, manufactured by Neos Therapeutics Brands, LLC, is $16.3218 per EA (NDC 62542002030), effective Jun 24, 2026.
How has the price of AMPHETAMINE ER 12.5 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 12.5 MG ODT has held within roughly two percent of its current level. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 12.5 MG ODT?
Since Dec 17, 2025, the NADAC for AMPHETAMINE ER 12.5 MG ODT has ranged from a low of $16.3218 (Jun 17, 2026) to a high of $16.5820 (Apr 15, 2026), with a median of $16.5570 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 12.5 MG ODT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMPHETAMINE ER 12.5 MG ODT, so no direct lower-cost alternative is listed.
Who manufactures AMPHETAMINE ER 12.5 MG ODT?
AMPHETAMINE ER 12.5 MG ODT (NDC 62542002030) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification